UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Galantamine and behavior in Alzheimer disease: analysis of four trials

Acta neurologica Scandinavica, 2011-11, Vol.124 (5), p.302-308

2011

Volltextzugriff (PDF)

Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate

Psychological medicine, 2012-01, Vol.42 (1), p.195-204

2012

Volltextzugriff (PDF)

PW01-63 - Functionality and quality of life in children and adolescents with ADHD transitioning to OROS MPH - correlations of outcomes

European psychiatry, 2010, Vol.25 (S1), p.1479-1479, Article 25-E1462

2010

Volltextzugriff (PDF)

YPSP01-02 - Effectiveness, quality of life and changes in burden of disease in children and adolescents with ADHD transitioning to OROS MPH

European psychiatry, 2010, Vol.25 (S1), p.1703-1703, Article 25-E1682

2010

Volltextzugriff (PDF)

Seizure and cognitive outcomes in children and adolescents with epilepsy treated with topiramate

Neuropediatrics, 2010-06, Vol.41 (3), p.113

2010

Volltextzugriff (PDF)

P.7.a.003 Efficacy of prolonged-release methylphenidate in a randomized controlled trial in adults with ADHD: secondary endpoints

European neuropsychopharmacology, 2009, Vol.19, p.S679-S680

2009

Volltextzugriff (PDF)

P03-347 Transitioning onto OROS MPH is associated with improved functioning and quality of life in children and adolescents with ADHD

European psychiatry, 2010, Vol.25 (S1), p.962-962, Article 25-E953

2010

Volltextzugriff (PDF)

P01-166 - Transitioning onto OROS MPH is associated with improved functioning and quality of life in adolescents with ADHD

European psychiatry, 2010, Vol.25 (S1), p.375-375, Article 25-E372

2010

Volltextzugriff (PDF)

P.1.c.025 Longterm safety and efficacy outcomes in adults with ADHD treated with prolonged-release methylphenidate

European neuropsychopharmacology, 2010, Vol.20, p.S249-S249

2010

Volltextzugriff (PDF)

Effectiveness of low dose of topiramate following rapid titration in multiply handicapped children and difficult-to-treat epilepsy

Neuropediatrics, 2009-04, Vol.40 (2), p.61

2009

Volltextzugriff (PDF)

Exploring efficacy and tolerability outcomes in patients with difficult-to-treat epilepsy receiving adjunctive topiramate at different titration rates - an exploratory study

Acta neurologica Scandinavica, 2009-08, Vol.120 (2), p.80-87

2009

Volltextzugriff (PDF)

P.7.a.002 A long-term safety study of prolonged-release methylphenidate in adults with ADHD

European neuropsychopharmacology, 2009, Vol.19, p.S679-S679

2009

Volltextzugriff (PDF)

P03-325 - Functional and symptomatic improvement in adults with ADHD - data from the open label extension of the lamda trial

European psychiatry, 2010, Vol.25 (S1), p.940-940, Article 25-E931

2010

Volltextzugriff (PDF)

P03-346 Effects of placebo-controlled withdrawal after long-term open label treatment with OROS MPH in adults with ADHD

European psychiatry, 2010, Vol.25 (S1), p.961-961, Article 25-E952

2010

Volltextzugriff (PDF)

P03-373 - Relation between symptomatic and functional outcomes in adults with ADHD treated with OROS MPH - a partial correlation analysis

European psychiatry, 2010, Vol.25 (S1), p.989-989, Article 25-E979

2010

Volltextzugriff (PDF)

Two galantamine titration regimens in patients switched from donepezil

Acta neurologica Scandinavica, 2012-07, Vol.126 (1), p.37-44

2012

Volltextzugriff (PDF)

Topiramat - Initiale Monotherapie bei älteren Patienten mit Epilepsie

Aktuelle Neurologie, 2007-06, Vol.34 (5), p.272-275

2007

Volltextzugriff (PDF)

Migraines with and without aura and their response to preventive therapy with topiramate

Cephalalgia, 2010-05, Vol.30 (5), p.543-551

2010

Volltextzugriff (PDF)

Histopathology, classification, and grading of gliomas

Glia, 1995-11, Vol.15 (3), p.211-221

1995

Volltextzugriff (PDF)

Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting

Current medical research and opinion, 2010-05, Vol.26 (5), p.1119-1129

2010

Volltextzugriff (PDF)

Infrequent alterations of the p15, p16, CDK4 and CYCLIN D1 genes in non‐astrocytic human brain tumors

International journal of cancer, 1996-05, Vol.66 (3), p.305-308

1996

Volltextzugriff (PDF)

Umstellung von Carbamazepin oder Oxcarbazepin auf Topiramat bei Jugendlichen und Erwachsenen mit Epilepsie

Clinical Epileptology, 2008-05, Vol.21 (2), p.69-78

2008

Volltextzugriff (PDF)

Wirksamkeit und Verträglichkeit von Topiramat bei Patienten mit Epilepsie nach erfolgloser Vorbehandlung mit Valproat

Aktuelle Neurologie, 2006, Vol.33 (S 1)

2006

Volltextzugriff (PDF)

Wirksamkeit und Verträglichkeit von Topiramat bei Patienten mit Epilepsie nach Umstellung von Carbamazepin oder Oxcarbazepin

Aktuelle Neurologie, 2006, Vol.33 (S 1)

2006

Volltextzugriff (PDF)

Validation of ablation model for polyethylene using pulsed x-ray and proton exposures

Journal of applied physics, 2022-12, Vol.132 (23)

2022

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Galantamine and behavior in Alzheimer disease: analysis of four trials

Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate

PW01-63 - Functionality and quality of life in children and adolescents with ADHD transitioning to OROS MPH - correlations of outcomes

YPSP01-02 - Effectiveness, quality of life and changes in burden of disease in children and adolescents with ADHD transitioning to OROS MPH

Seizure and cognitive outcomes in children and adolescents with epilepsy treated with topiramate

P.7.a.003 Efficacy of prolonged-release methylphenidate in a randomized controlled trial in adults with ADHD: secondary endpoints

P03-347 Transitioning onto OROS MPH is associated with improved functioning and quality of life in children and adolescents with ADHD

P01-166 - Transitioning onto OROS MPH is associated with improved functioning and quality of life in adolescents with ADHD

P.1.c.025 Longterm safety and efficacy outcomes in adults with ADHD treated with prolonged-release methylphenidate

Effectiveness of low dose of topiramate following rapid titration in multiply handicapped children and difficult-to-treat epilepsy

Exploring efficacy and tolerability outcomes in patients with difficult-to-treat epilepsy receiving adjunctive topiramate at different titration rates - an exploratory study

P.7.a.002 A long-term safety study of prolonged-release methylphenidate in adults with ADHD

P03-325 - Functional and symptomatic improvement in adults with ADHD - data from the open label extension of the lamda trial

P03-346 Effects of placebo-controlled withdrawal after long-term open label treatment with OROS MPH in adults with ADHD

P03-373 - Relation between symptomatic and functional outcomes in adults with ADHD treated with OROS MPH - a partial correlation analysis

Two galantamine titration regimens in patients switched from donepezil

Topiramat - Initiale Monotherapie bei älteren Patienten mit Epilepsie

Migraines with and without aura and their response to preventive therapy with topiramate

Histopathology, classification, and grading of gliomas

Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting

Infrequent alterations of the p15, p16, CDK4 and CYCLIN D1 genes in non‐astrocytic human brain tumors

Umstellung von Carbamazepin oder Oxcarbazepin auf Topiramat bei Jugendlichen und Erwachsenen mit Epilepsie

Wirksamkeit und Verträglichkeit von Topiramat bei Patienten mit Epilepsie nach erfolgloser Vorbehandlung mit Valproat

Wirksamkeit und Verträglichkeit von Topiramat bei Patienten mit Epilepsie nach Umstellung von Carbamazepin oder Oxcarbazepin

Validation of ablation model for polyethylene using pulsed x-ray and proton exposures

Suchergebnisse filtern